Scientists probe immune weakness in ovarian cancer to unlock new treatments
NCT ID NCT06611072
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to understand why the immune system fails to fight ovarian cancer effectively. Researchers will compare blood, bone marrow, and immune cells from 90 women with ovarian cancer and healthy controls. The goal is to find ways to reprogram immune cells to attack the tumor, potentially leading to future therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNE SUPPRESSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Catharina Hospital
RECRUITINGEindhoven, North Brabant, 5623EJ, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple blood test spot ovarian cancer before it starts?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Can a new PET tracer light up hidden cancers?
- A Two-for-One surgery: could tube removal during Weight-Loss surgery slash ovarian cancer risk?
- Can AI spot ovarian cancer on CT scans before It's too late?
- Can Lab-Grown tumors unlock the secrets of ovarian cancer resistance?